Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.24.3
Stockholders’ Equity (Details) - USD ($)
 3 Months Ended 12 Months Ended
Aug. 30, 2024
Aug. 31, 2024
Aug. 31, 2023
May 31, 2024
Stockholders’ Equity (Details) [Line Items]        
Common Stock, Shares Authorized (in Shares)   345,000,000   345,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)   $ 0.0001   $ 0.0001
Preferred Stock, Shares Authorized (in Shares)   5,000,000   5,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)   $ 0.001   $ 0.001
Debt Conversion, Converted Instrument, Shares Issued (in Shares) 56,847,545      
Debt Conversion, Original Debt, Amount $ 2,200,000 $ 2,200,000 $ 0  
Class of Warrant or Rights, Cancelled or Expired (in Shares)   0   (454,548)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value   $ 5,344 0  
Share Price (in Dollars per share)   $ 0.043    
Share-Based Payment Arrangement, Option [Member]        
Stockholders’ Equity (Details) [Line Items]        
Share-Based Payment Arrangement, Expense   $ 28,802 $ 0  
Canaccord Debentures [Member]        
Stockholders’ Equity (Details) [Line Items]        
Class of Warrant or Rights, Cancelled or Expired (in Shares)   41,667